Thomas Serwold News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Thomas serwold. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Thomas Serwold Today - Breaking & Trending Today

Lab-made killer T cell attacks cells that cause diabetes


The work could lead to new immunotherapy treatments.
The immune system fights bacteria, viruses, and other pathogens by utilizing several types of T cells, all of which have receptors that are specific to particular antigens. On killer T cells, the receptor works in concert with three signaling modules and a coreceptor to destroy the infected cell.
“When we saw that the 5MCAR T cells completely eliminated the harmful T cells that invaded the pancreas, we were blown away.”
The researchers copied the evolutionary design to engineer a five-module chimeric antigen receptor, or 5MCAR, T cell.
“The 5MCAR was an attempt to figure out if we could build something by biomimicry, using some of evolution’s natural pieces, and redirect T cells to do what we want them to do. We engineered a 5MCAR that would direct killer T cells to target autoimmune T cells that mediate type 1 diabetes,” says Michael Kuhns, an associate professor in the immunobiology department at the ....

United States , University Of Arizona , Michael Kuhns , Thomas Serwold , National Institute Of Allergy , National Institutes Of Health , Cancer Center , Drug Administration , Proceedings Of The National Academy Sciences , Uarizona Center On , Harvard Medical Joslin Diabetes Center , University Of Arizona College Medicine , Arizona College , Arizona Center , National Academy , National Institute , Infectious Diseases , National Institutes , ஒன்றுபட்டது மாநிலங்களில் , பல்கலைக்கழகம் ஆஃப் அரிசோனா , மைக்கேல் குன்ஸ் , தேசிய நிறுவனம் ஆஃப் ஒவ்வாமை , தேசிய நிறுவனங்கள் ஆஃப் ஆரோக்கியம் , புற்றுநோய் மையம் , அரிசோனா மையம் ஆன் , ஹார்வர்ட் மருத்துவ ஜோஸ்லின் நீரிழிவு நோய் மையம் ,